{
  "dataset": "Strategic Signal — Corporate AI Data Transactions",
  "dataset_version": "1.0.16",
  "methodology_version": "1.0.0",
  "released_on": "2026-10-01",
  "observation_count": 17,
  "approved_record_count": 12,
  "change_type": "reviewed_addition",
  "previous_version": "1.0.15",
  "changes": [
    "SS-AIDT-2026-0015: Mike Ye approved the Ginkgo Datapoints/Apheris Antibody Developability Consortium canonical AI Access event as strict data-rights qualified. The arrangement provides governed federated learning rights over proprietary antibody sequences and standardized assay data while members retain ownership and raw sequences remain protected. AI Data Asset Score 90; Transaction Signal Score 51."
  ],
  "known_limits": [
    "Only human_reviewed records count as approved observations.",
    "Bundled commitments and pending bids are not dataset purchase prices."
  ]
}